2.4.1.9 Html 101 214 1 false 42 0 false 5 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.kytherabiopharma.com/role/DocumentDocumentAndEntityInformation Document and Entity Information true false R2.htm 00100 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.kytherabiopharma.com/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets false false R3.htm 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.kytherabiopharma.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) false false R4.htm 00200 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.kytherabiopharma.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss false false R5.htm 00300 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.kytherabiopharma.com/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows false false R6.htm 10101 - Disclosure - Organization Sheet http://www.kytherabiopharma.com/role/DisclosureOrganization Organization false false R7.htm 10201 - Disclosure - Summary of Significant Accounting Policies and Basis of Presentation Sheet http://www.kytherabiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndBasisOfPresentation Summary of Significant Accounting Policies and Basis of Presentation false false R8.htm 10301 - Disclosure - Marketable Securities Sheet http://www.kytherabiopharma.com/role/DisclosureMarketableSecurities Marketable Securities false false R9.htm 10401 - Disclosure - Notes Payable Notes http://www.kytherabiopharma.com/role/DisclosureNotesPayable Notes Payable false false R10.htm 10501 - Disclosure - Stockholders' Equity Sheet http://www.kytherabiopharma.com/role/DisclosureStockholdersEquity Stockholders' Equity false false R11.htm 10601 - Disclosure - Collaborations, Licensing and Contingencies Sheet http://www.kytherabiopharma.com/role/DisclosureCollaborationsLicensingAndContingencies Collaborations, Licensing and Contingencies false false R12.htm 10701 - Disclosure - Fair Value Measurements Sheet http://www.kytherabiopharma.com/role/DisclosureFairValueMeasurements Fair Value Measurements false false R13.htm 10801 - Disclosure - Income Taxes Sheet http://www.kytherabiopharma.com/role/DisclosureIncomeTaxes Income Taxes false false R14.htm 10901 - Disclosure - Basic and Diluted Net Loss Per Common Share Sheet http://www.kytherabiopharma.com/role/DisclosureBasicAndDilutedNetLossPerCommonShare Basic and Diluted Net Loss Per Common Share false false R15.htm 11001 - Disclosure - Subsequent Events Sheet http://www.kytherabiopharma.com/role/DisclosureSubsequentEvents Subsequent Events false false R16.htm 20202 - Disclosure - Summary of Significant Accounting Policies and Basis of Presentation (Policies) Sheet http://www.kytherabiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndBasisOfPresentationPolicies Summary of Significant Accounting Policies and Basis of Presentation (Policies) false false R17.htm 30203 - Disclosure - Summary of Significant Accounting Policies and Basis of Presentation (Tables) Sheet http://www.kytherabiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndBasisOfPresentationTables Summary of Significant Accounting Policies and Basis of Presentation (Tables) false false R18.htm 30303 - Disclosure - Marketable Securities (Tables) Sheet http://www.kytherabiopharma.com/role/DisclosureMarketableSecuritiesTables Marketable Securities (Tables) false false R19.htm 30403 - Disclosure - Notes Payable (Tables) Notes http://www.kytherabiopharma.com/role/DisclosureNotesPayableTables Notes Payable (Tables) false false R20.htm 30503 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.kytherabiopharma.com/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) false false R21.htm 30603 - Disclosure - Collaborations, Licensing and Contingencies (Tables) Sheet http://www.kytherabiopharma.com/role/DisclosureCollaborationsLicensingAndContingenciesTables Collaborations, Licensing and Contingencies (Tables) false false R22.htm 30703 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.kytherabiopharma.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) false false R23.htm 40101 - Disclosure - Organization (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureOrganizationDetails Organization (Details) false false R24.htm 40201 - Disclosure - Summary of Significant Accounting Policies and Basis of Presentation (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndBasisOfPresentationDetails Summary of Significant Accounting Policies and Basis of Presentation (Details) false false R25.htm 40202 - Disclosure - Summary of Significant Accounting Policies and Basis of Presentation (Details 2) Sheet http://www.kytherabiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndBasisOfPresentationDetails2 Summary of Significant Accounting Policies and Basis of Presentation (Details 2) false false R26.htm 40301 - Disclosure - Marketable Securities (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureMarketableSecuritiesDetails Marketable Securities (Details) false false R27.htm 40401 - Disclosure - Notes Payable (Details) Notes http://www.kytherabiopharma.com/role/DisclosureNotesPayableDetails Notes Payable (Details) false false R28.htm 40501 - Disclosure - Stockholders' Equity (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureStockholdersEquityDetails Stockholders' Equity (Details) false false R29.htm 40502 - Disclosure - Stockholders' Equity (Details 2) Sheet http://www.kytherabiopharma.com/role/DisclosureStockholdersEquityDetails2 Stockholders' Equity (Details 2) false false R30.htm 40503 - Disclosure - Stockholders' Equity (Details 3) Sheet http://www.kytherabiopharma.com/role/DisclosureStockholdersEquityDetails3 Stockholders' Equity (Details 3) false false R31.htm 40504 - Disclosure - Stockholders' Equity (Details 4) Sheet http://www.kytherabiopharma.com/role/DisclosureStockholdersEquityDetails4 Stockholders' Equity (Details 4) false false R32.htm 40601 - Disclosure - Collaborations, Licensing and Contingencies (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureCollaborationsLicensingAndContingenciesDetails Collaborations, Licensing and Contingencies (Details) false false R33.htm 40701 - Disclosure - Fair Value Measurements (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureFairValueMeasurementsDetails Fair Value Measurements (Details) false false R34.htm 40801 - Disclosure - Income Taxes (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) false false R35.htm 40901 - Disclosure - Basic and Diluted Net Loss Per Common Share (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureBasicAndDilutedNetLossPerCommonShareDetails Basic and Diluted Net Loss Per Common Share (Details) false false R36.htm 41001 - Disclosure - Subsequent Events (Details) Sheet http://www.kytherabiopharma.com/role/DisclosureSubsequentEventsDetails Subsequent Events (Details) false false All Reports Book All Reports Element us-gaap_InterestPayableCurrent had a mix of decimals attribute values: -5 -3. Element us-gaap_ProceedsFromIssuanceOfCommonStock had a mix of decimals attribute values: -5 -3. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized had a mix of decimals attribute values: -5 -3. 'Monetary' elements on report '40401 - Disclosure - Notes Payable (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '40504 - Disclosure - Stockholders' Equity (Details 4)' had a mix of different decimal attribute values. 'Monetary' elements on report '40601 - Disclosure - Collaborations, Licensing and Contingencies (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '41001 - Disclosure - Subsequent Events (Details)' had a mix of different decimal attribute values. Process Flow-Through: 00100 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Mar. 31, 2014' Process Flow-Through: Removing column 'Dec. 31, 2013' Process Flow-Through: 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 00200 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Process Flow-Through: 00300 - Statement - Condensed Consolidated Statements of Cash Flows kyth-20150331.xml kyth-20150331.xsd kyth-20150331_cal.xml kyth-20150331_def.xml kyth-20150331_lab.xml kyth-20150331_pre.xml true true